News

Filter

Current filters:

None

Popular Filters

7801 to 7825 of 8831 results

Pfizer tops social media presence ranking

19-12-2011

Cegedim Strategic Data (CSD), a provider of integrated health care market research and worldwide promotional…

Markets & MarketingMerck & CoNovartisPfizerPharmaceutical

Plant molecular farming: a new Biotech Wave

19-12-2011

Currently, the two approved methods of biopharmaceuticals manufacturing widely used in Europe are mammalian…

BASFBayerBiotechnologyPharmaceuticalResearch

COPD market to grow to more than $13.4 billion in 2020

19-12-2011

As a result of an expanding aging population, increases in drug treatment and the uptake of premium priced…

Boehringer IngelheimGlobalMarkets & MarketingolodaterolPharmaceuticalRespiratory and Pulmonarytiotropium

EMA recommends approval of Roche’s Zelboraf

19-12-2011

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended…

Daiichi SankyoEuropeOncologyPharmaceuticalRegulationRocheZelboraf

Gilead filing of Truvada for PrEP looks contentious

19-12-2011

US biotech firm Gilead Sciences’ (Nasdaq: GILD) decision last week to submit a supplemental New…

Anti-viralsBiotechnologyGilead SciencesNorth AmericaPharmaceuticalRegulationTruvada

Takeda to drop peginesatide commercialization in Japan

19-12-2011

Japan’s largest drugmaker Takeda Pharmaceutical (TYO: 4502) has decided not to commercialize peginesatide…

AffymaxAsia-PacificLicensingNephrology and HepatologypeginesatidePharmaceuticalTakeda Pharmaceuticals

Musical chairs at Amgen and Roche

19-12-2011

USA-based Amgen (Nasdaq: AMGN), the world’s largest independent biotech company, says that Kevin…

AmgenBiotechnologyManagementPharmaceuticalRoche

Germany’s IQWIG negative on InterMune’s Esbriet

18-12-2011

US biotech firm InterMune (Nasdaq: ITMN) says that Germany’s private Institute for Quality and Efficiency…

BiotechnologyEsbrietEuropeInterMuneRare diseasesRegulationRespiratory and Pulmonary

Ipsen invests $45 million in US R&D facility

18-12-2011

French drugmaker Ipsen (Euronext: IPN) says its USA-based subsidiary, Biomeasure and its North American…

FinancialIpsenNorth AmericaPharmaceuticalResearch

European Medicines Agency’s 2012 work program and budget

18-12-2011

The European Medicines Agency’s Management Board, at its meeting on 15 December 15, adopted the…

BiotechnologyEuropeFinancialGenericsPharmaceuticalRegulationResearch

US Admin and GPhA moves to prevent drug shortages

18-12-2011

In response to US President Barack Obama’s Executive Order of October 31 (The Pharma Letter November…

GenericsMarkets & MarketingNorth AmericaPharmaceuticalRegulation

Australia’s new PBS prices will drive significant savings, says GMiA

18-12-2011

The new prices for medicines affected by the price disclosure policy on the Australian Pharmaceutical…

Asia-PacificGenericsPharmaceuticalPricing

Brilique first drug to gain post-AMNOG decision in Germany

16-12-2011

The German health assessment body, the Federal Joint Committee (G-BA), has issued its final decision…

BriliqueCardio-vascularEuropePharmaceuticalPricingRegulation

Covidien to spin off pharmaceuticals business

16-12-2011

US medical products and generic drugmaker Covidien (NYSE: COV) says that it plans to spin off its pharmaceuticals…

CovidienGenericsMergers & AcquisitionsNeurologicalPharmaceutical

Where to now for UK Life Sciences?

16-12-2011

The 2012 UK Life Science Industry Leaders Survey* highlights a concern that the UK is losing its position…

BiotechnologyEuropeFinancialPharmaceuticalPricingRegulationResearch

Vertex updates on US and EU Kalydeco filings; to get new CEO

16-12-2011

US drugmaker Vertex Pharmaceuticals (Nasdaq: VRTX) says that the US Food and Drug Administration has…

EuropeKalydecoManagementNorth AmericaPharmaceuticalRare diseasesRegulationVertex

BioSante female libido drug flops in Ph III studies

16-12-2011

its two pivotal Phase III LibiGel (testosterone gel) efficacy trials, joining the list of failures in…

BioSante PharmaceuticalsBiotechnologyLibiGelResearchWomen's Health

Isis sees Kynamro delay; adds new drugs to pipeline

15-12-2011

California, USA-based Isis Pharmaceuticals (Nasdaq: ISIS) announced yesterday that there will be a slight…

Cardio-vascularGenzymeIsis PharmaceuticalsKynamromipomersenNephrology and HepatologyPharmaceuticalRegulationResearchSanofi

Intellect Neurosciences appeals European patent decision

15-12-2011

US neuro drug discovery firm Intellect Neurosciences (OTCBB: ILNS) says that it has filed an appeal regarding…

bapineuzumabBiotechnologyElanIntellect NeuroscienceLegalNeurologicalPatentsPfizerPharmaceutical

Investment in medicines highest in PHARMAC history

15-12-2011

A surge in the medicines budget over the past three years, combined with New Zealand’s health regulatory…

Asia-PacificBiotechnologyFinancialPharmaceuticalPricingRegulation

Russia’s NSCLC market set to grow to $163 million in 2015

15-12-2011

The Russian market for non-small-cell lung cancer (NSCLC) therapies will grow 3% annually from 2010 to…

EuropeMarkets & MarketingOncologyPharmaceutical

HIV funding in developing countries needs more transparency; report

15-12-2011

With the need for HIV services in developing countries rising and the availability of funding flat or…

Anti-viralsFinancialHealthcarePharmaceutical

7801 to 7825 of 8831 results

Back to top